Pretreatment H2 receptor antagonists that differ in P450 modulation activity: comparative effects on paclitaxel clearance rates and neutropenia
- 1 January 1995
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 36 (3) , 227-232
- https://doi.org/10.1007/bf00685851
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Selective Inhibitors of Cytochromes P450Toxicology and Applied Pharmacology, 1994
- Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.Journal of Clinical Oncology, 1993
- Sequences of taxol and cisplatin: a phase I and pharmacologic study.Journal of Clinical Oncology, 1991
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990
- Pharmacokinetic Interactions of Cimetidine 1987Clinical Pharmacokinetics, 1987
- Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteers [letter]Published by Wiley ,1984
- Effects of infused histamine: analysis of the effects of H-1 and H-2 histamine receptor antagonists on cardiovascular and pulmonary responsesJournal of Allergy and Clinical Immunology, 1981
- Introduction to sample size determination and power analysis for clinical trialsControlled Clinical Trials, 1981
- Pretreatment of high-risk patients requiring radiographic contrast media studiesJournal of Allergy and Clinical Immunology, 1981
- Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituentInflammation Research, 1977